{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:54:44Z","timestamp":1780084484156,"version":"3.54.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK135933"],"award-info":[{"award-number":["DK135933"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urolithiasis"],"DOI":"10.1007\/s00240-025-01758-5","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T17:47:37Z","timestamp":1746640057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Increased risk of upper tract urothelial carcinoma in patients with kidney stones: a large-scale analysis of the UK biobank"],"prefix":"10.1007","volume":"53","author":[{"given":"Hachem","family":"Ziadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Calaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Bodner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrick R.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Han Wilfred","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"1758_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00345-017-2008-6","volume":"35","author":"I Sorokin","year":"2017","unstructured":"Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y (2017) Epidemiology of stone disease across the world. World J Urol 35:1301\u20131320","journal-title":"World J Urol"},{"key":"1758_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.uroco.2015.12.013","volume":"25","author":"HA Garc\u00eda-Perdomo","year":"2016","unstructured":"Garc\u00eda-Perdomo HA, Solarte PB, Espa\u00f1a PP (2016) Pathophysiology associated with forming urinary stones. Urol Colomb 25:118\u2013125","journal-title":"Urol Colomb"},{"key":"1758_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.euros.2021.10.008","volume":"35","author":"J Lang","year":"2022","unstructured":"Lang J, Narendrula A, El-Zawahry A, Sindhwani P, Ekwenna O (2022) Global trends in incidence and burden of urolithiasis from 1990 to 2019: an analysis of global burden of disease study data. Eur Urol Open Sci 35:37\u201346","journal-title":"Eur Urol Open Sci"},{"key":"1758_CR4","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1517\/14656566.2015.1037740","volume":"16","author":"S Sfoungaristos","year":"2015","unstructured":"Sfoungaristos S, Gofrit ON, Yutkin V, Pode D, Duvdevani M (2015) Prevention of renal stone disease recurrence. A systematic review of contemporary pharmaceutical options. Expert Opin Pharmacother 16:1209\u20131218","journal-title":"Expert Opin Pharmacother"},{"key":"1758_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/2051415818813820","author":"Z Chen","year":"2018","unstructured":"Chen Z, Prosperi M, Bird VY (2018) Prevalence of kidney stones in the USA: the national health and nutrition evaluation survey. J Clin Urol. https:\/\/doi.org\/10.1177\/2051415818813820","journal-title":"J Clin Urol"},{"key":"1758_CR6","first-page":"e86","volume":"12","author":"V Romero","year":"2010","unstructured":"Romero V, Akpinar H, Assimos DG (2010) Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12:e86-96","journal-title":"Rev Urol"},{"key":"1758_CR7","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/j.1464-410X.2011.10495.x","volume":"109","author":"BW Turney","year":"2012","unstructured":"Turney BW, Reynard JM, Noble JG, Keoghane SR (2012) Trends in urological stone disease. BJU Int 109:1082\u20131087","journal-title":"BJU Int"},{"key":"1758_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1159\/000449510","volume":"98","author":"NJ Rukin","year":"2017","unstructured":"Rukin NJ, Siddiqui ZA, Chedgy ECP, Somani BK (2017) Trends in upper tract stone disease in England: evidence from the hospital episodes statistics database. Urol Int 98:391\u2013396","journal-title":"Urol Int"},{"key":"1758_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4111\/kju.2010.51.3.193","volume":"51","author":"AA Ahmed","year":"2010","unstructured":"Ahmed AA, Al-sayed AS (2010) Tamsulosin versus Alfuzosin in the treatment of patients with distal ureteral stones: prospective, randomized. Comp Study Korean J Urol 51:193","journal-title":"Comp Study Korean J Urol"},{"key":"1758_CR10","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0022-5347(17)40037-1","volume":"143","author":"AR Crowley","year":"1990","unstructured":"Crowley AR, Byrne JC, Vaughan ED, Marion DN (1990) The effect of acute obstruction on ureteral function. J Urol 143:596\u2013599","journal-title":"J Urol"},{"key":"1758_CR11","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","volume":"9","author":"L Chen","year":"2017","unstructured":"Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L (2017) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9:7204\u20137218","journal-title":"Oncotarget"},{"key":"1758_CR12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.190.10.1367","volume":"190","author":"C Cordon-Cardo","year":"1999","unstructured":"Cordon-Cardo C, Prives C (1999) At the crossroads of inflammation and tumorigenesis. J Exp Med 190:1367\u20131370","journal-title":"J Exp Med"},{"key":"1758_CR13","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/435752a","volume":"435","author":"A Mantovani","year":"2005","unstructured":"Mantovani A (2005) Inflammation by remote control. Nature 435:752\u2013753","journal-title":"Nature"},{"key":"1758_CR14","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.7326\/0003-4819-111-12-1006","volume":"111","author":"J Uribarri","year":"1989","unstructured":"Uribarri J, Oh MS, Carroll HJ (1989) The first kidney stone. Ann Intern Med 111:1006\u20131009","journal-title":"Ann Intern Med"},{"key":"1758_CR15","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1681\/ASN.2013091011","volume":"25","author":"AD Rule","year":"2014","unstructured":"Rule AD, Lieske JC, Li X, Melton LJ, Krambeck AE, Bergstralh EJ (2014) The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol JASN 25:2878\u20132886","journal-title":"J Am Soc Nephrol JASN"},{"key":"1758_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(06)68071-9","volume":"367","author":"OW Moe","year":"2006","unstructured":"Moe OW (2006) Kidney stones: pathophysiology and medical management. Lancet 367:333\u2013344","journal-title":"Lancet"},{"key":"1758_CR17","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/ki.1994.224","volume":"45","author":"JH Parks","year":"1994","unstructured":"Parks JH, Coe FL (1994) An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney Int 45:1722\u20131730","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"1758_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000104439","volume":"79","author":"R Miano","year":"2007","unstructured":"Miano R, Germani S, Vespasiani G (2007) Stones and urinary tract infections. Urol Int 79(Suppl 1):32\u201336","journal-title":"Urol Int"},{"key":"1758_CR19","doi-asserted-by":"publisher","first-page":"l1652","DOI":"10.1136\/bmj.l1652","volume":"365","author":"CJM de Blok","year":"2019","unstructured":"de Blok CJM, Wiepjes CM, Nota NM, van Engelen K, Adank MA, Dreijerink KMA, Barb\u00e9 E, Konings IRHM, den Heijer M (2019) Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ 365:l1652","journal-title":"BMJ"},{"key":"1758_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41416-018-0356-7","volume":"120","author":"JAA van de Pol","year":"2019","unstructured":"van de Pol JAA, van den Brandt PA, Schouten LJ (2019) Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: the Netherlands cohort study. Br J Cancer 120:368\u2013374","journal-title":"Br J Cancer"},{"key":"1758_CR21","first-page":"205","volume":"108","author":"W Cheungpasitporn","year":"2015","unstructured":"Cheungpasitporn W, Thongprayoon C, O\u2019Corragain OA, Edmonds PJ, Ungprasert P, Kittanamongkolchai W, Erickson SB (2015) The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis. QJM Mon J Assoc Phys 108:205\u2013212","journal-title":"QJM Mon J Assoc Phys"},{"key":"1758_CR22","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/jnci\/89.19.1453","volume":"89","author":"WH Chow","year":"1997","unstructured":"Chow WH, Lindblad P, Gridley G, Nyr\u00e9n O, McLaughlin JK, Linet MS, Pennello GA, Adami HO, Fraumeni JF (1997) Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst 89:1453\u20131457","journal-title":"J Natl Cancer Inst"},{"key":"1758_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/aje\/kwh014","volume":"159","author":"AS Parker","year":"2004","unstructured":"Parker AS, Cerhan JR, Lynch CF, Leibovich BC, Cantor KP (2004) History of urinary tract infection and risk of renal cell carcinoma. Am J Epidemiol 159:42\u201348","journal-title":"Am J Epidemiol"},{"key":"1758_CR24","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1002\/ijc.23192","volume":"121","author":"A Federico","year":"2007","unstructured":"Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C (2007) Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121:2381\u20132386","journal-title":"Int J Cancer"},{"key":"1758_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrc1256","volume":"4","author":"JW Pollard","year":"2004","unstructured":"Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71\u201378","journal-title":"Nat Rev Cancer"},{"key":"1758_CR26","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1093\/carcin\/16.11.2773","volume":"16","author":"H Ogasawara","year":"1995","unstructured":"Ogasawara H, Imaida K, Ishiwata H, Toyoda K, Kawanishi T, Uneyama C, Hayashi S, Takahashi M, Hayashi Y (1995) Urinary bladder carcinogenesis induced by melamine in F344 male rats: correlation between carcinogenicity and urolith formation. Carcinogenesis 16:2773\u20132777","journal-title":"Carcinogenesis"}],"container-title":["Urolithiasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-025-01758-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00240-025-01758-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-025-01758-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T23:02:58Z","timestamp":1766530978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00240-025-01758-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1758"],"URL":"https:\/\/doi.org\/10.1007\/s00240-025-01758-5","relation":{},"ISSN":["2194-7236"],"issn-type":[{"value":"2194-7236","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"22 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Adam Calaway: Key Opinion Leader at Fortec Medical; Received support for attending meetings and\/or travel to ASCO GU 2024 from ASCO.\u2014Sanjay Gupta: Received support for attending meetings and\/or travel from Cancers-MDPI journal.\u2014Jason Brown: Speakers\u2019 Bureau at EMD Serono; Travel support from Janssen; Scientific Advisory Board at EMD Serono, Janssen, and Pfizer.\u2014Chen-Han Wilfred Wu is a member of the Executive Committee for the Harrington Scholar-Innovator Award Program, and conducts clinical trials with ModernaTx, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The UK Biobank study was approved by the National Health Service (NHS) Northwest Centre for Research Ethics Committee (Ref: 11\/NW\/0382). Our research has been conducted using the UK Biobank resource under application number 87480.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"87"}}